83 related articles for article (PubMed ID: 30415825)
1. SBF-1 preferentially inhibits growth of highly malignant human liposarcoma cells.
Chen W; Qian X; Hu Y; Jin W; Shan Y; Fang X; Sun Y; Yu B; Luo Q; Xu Q
J Pharmacol Sci; 2018 Dec; 138(4):271-278. PubMed ID: 30415825
[TBL] [Abstract][Full Text] [Related]
2. Preferential cytotoxicity of bortezomib toward highly malignant human liposarcoma cells via suppression of MDR1 expression and function.
Hu Y; Wang L; Wang L; Wu X; Wu X; Gu Y; Shu Y; Sun Y; Shen Y; Xu Q
Toxicol Appl Pharmacol; 2015 Feb; 283(1):1-8. PubMed ID: 25576094
[TBL] [Abstract][Full Text] [Related]
3. SBF-1, a synthetic steroidal glycoside, inhibits melanoma growth and metastasis through blocking interaction between PDK1 and AKT3.
Li W; Song R; Fang X; Wang L; Chen W; Tang P; Yu B; Sun Y; Xu Q
Biochem Pharmacol; 2012 Jul; 84(2):172-81. PubMed ID: 22525724
[TBL] [Abstract][Full Text] [Related]
4. SBF-1 exerts strong anticervical cancer effect through inducing endoplasmic reticulum stress-associated cell death via targeting sarco/endoplasmic reticulum Ca(2+)-ATPase 2.
Li W; Ouyang Z; Zhang Q; Wang L; Shen Y; Wu X; Gu Y; Shu Y; Yu B; Wu X; Sun Y; Xu Q
Cell Death Dis; 2014 Dec; 5(12):e1581. PubMed ID: 25522275
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells.
Harati K; Daigeler A; Hirsch T; Jacobsen F; Behr B; Wallner C; Lehnhardt M; Becerikli M
Int J Mol Med; 2016 Jun; 37(6):1535-41. PubMed ID: 27082154
[TBL] [Abstract][Full Text] [Related]
6. TP53INP2-related basal autophagy is involved in the growth and malignant progression in human liposarcoma cells.
Hu Y; Li X; Xue W; Pang J; Meng Y; Shen Y; Xu Q
Biomed Pharmacother; 2017 Apr; 88():562-568. PubMed ID: 28131096
[TBL] [Abstract][Full Text] [Related]
7. Natural products reveal cancer cell dependence on oxysterol-binding proteins.
Burgett AW; Poulsen TB; Wangkanont K; Anderson DR; Kikuchi C; Shimada K; Okubo S; Fortner KC; Mimaki Y; Kuroda M; Murphy JP; Schwalb DJ; Petrella EC; Cornella-Taracido I; Schirle M; Tallarico JA; Shair MD
Nat Chem Biol; 2011 Aug; 7(9):639-47. PubMed ID: 21822274
[TBL] [Abstract][Full Text] [Related]
8. Growth-Suppressive and Apoptosis-Inducing Effects of Tetrandrine in SW872 Human Malignant Liposarcoma Cells via Activation of Caspase-9, Down-Regulation of XIAP and STAT-3, and ER Stress.
Samsuzzaman M; Jang BC
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740967
[TBL] [Abstract][Full Text] [Related]
9. Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1.
Chow WA; Guo S; Valdes-Albini F
Anticancer Drugs; 2006 Sep; 17(8):891-903. PubMed ID: 16940799
[TBL] [Abstract][Full Text] [Related]
10. High expression of sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase 2b blocks cell differentiation in human liposarcoma cells.
Wang L; Li W; Yang Y; Hu Y; Gu Y; Shu Y; Sun Y; Wu X; Shen Y; Xu Q
Life Sci; 2014 Mar; 99(1-2):37-43. PubMed ID: 24508653
[TBL] [Abstract][Full Text] [Related]
11. Anticancer saponin OSW-1 is a novel class of selective Golgi stress inducer.
Kimura M; Sasaki K; Fukutani Y; Yoshida H; Ohsawa I; Yohda M; Sakurai K
Bioorg Med Chem Lett; 2019 Jul; 29(14):1732-1736. PubMed ID: 31126855
[TBL] [Abstract][Full Text] [Related]
12. Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP.
Albulescu L; Strating JR; Thibaut HJ; van der Linden L; Shair MD; Neyts J; van Kuppeveld FJ
Antiviral Res; 2015 May; 117():110-4. PubMed ID: 25752737
[TBL] [Abstract][Full Text] [Related]
13. miR-195 Serves as a Tumor Suppressor in the Progression of Liposarcoma by Targeting OSBP.
Cao Y; Li L; Han L; Zheng J; Lv C
Onco Targets Ther; 2020; 13():6465-6474. PubMed ID: 32753887
[TBL] [Abstract][Full Text] [Related]
14. SBF-1 inhibits contact hypersensitivity in mice through down-regulation of T-cell-mediated responses.
Chen W; Fang X; Gao Y; Shi K; Sun L; Yu B; Luo Q; Xu Q
BMC Pharmacol Toxicol; 2019 Dec; 20(1):86. PubMed ID: 31864413
[TBL] [Abstract][Full Text] [Related]
15. Uncovering oxysterol-binding protein (OSBP) as a target of the anti-enteroviral compound TTP-8307.
Albulescu L; Bigay J; Biswas B; Weber-Boyvat M; Dorobantu CM; Delang L; van der Schaar HM; Jung YS; Neyts J; Olkkonen VM; van Kuppeveld FJM; Strating JRPM
Antiviral Res; 2017 Apr; 140():37-44. PubMed ID: 28088354
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the interaction between Bcr-Abl and PTB1B by small molecule SBF-1 to overcome imatinib-resistance of chronic myeloid leukemia cells.
Elgehama A; Chen W; Pang J; Mi S; Li J; Guo W; Wang X; Gao J; Yu B; Shen Y; Xu Q
Cancer Lett; 2016 Mar; 372(1):82-8. PubMed ID: 26721204
[TBL] [Abstract][Full Text] [Related]
17. Integrin α6(high) cell population functions as an initiator in tumorigenesis and relapse of human liposarcoma.
Wang L; Wang L; Gu Y; Shu Y; Shen Y; Xu Q
Mol Cancer Ther; 2011 Dec; 10(12):2276-86. PubMed ID: 21980129
[TBL] [Abstract][Full Text] [Related]
18. Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model.
Nam S; Kim H; Hong D; Park JB; Kim SJ
Anticancer Res; 2017 Nov; 37(11):6291-6302. PubMed ID: 29061812
[TBL] [Abstract][Full Text] [Related]
19. Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6.
Guan M; Fousek K; Jiang C; Guo S; Synold T; Xi B; Shih CC; Chow WA
Clin Cancer Res; 2011 Apr; 17(7):1796-806. PubMed ID: 21355074
[TBL] [Abstract][Full Text] [Related]
20. TAT-OSBP-1-MKK6(E), a novel TAT-fusion protein with high selectivity for human ovarian cancer, exhibits anti-tumor activity.
Zhong J; Kang J; Wang X; Jiang W; Liao H; Yuan J
Med Oncol; 2015 Apr; 32(4):118. PubMed ID: 25782870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
